Oral administration (PO) of the construct expressing the P. aeruginosa (PA103) serogroup O11 in acute pneumonia models provided better protection than intraperitoneal (IP) administration and induced strong immunoglobulin G (IgG) and IgA responses [62]. The gene discussed is CD79A; the disease is pneumonia.